Valneva Signs an Agreement to Acquire Dukoral® Vaccine Agreement includes Crucell Sweden AB, the Dukoral franchise and Nordic vaccine sales infrastructure Lyon (France), January 5, 2015 – European biotechnology compan - Cholera vaccine - Document - PDFSEARCH.IO

First Page	Meta Content
	Valneva Signs an Agreement to Acquire Dukoral® Vaccine Agreement includes Crucell Sweden AB, the Dukoral franchise and Nordic vaccine sales infrastructure Lyon (France), January 5, 2015 – European biotechnology compan Add to Reading List Document Date: 2015-01-07 02:33:27 Open Document File Size: 442,18 KB Share Result on Facebook City Lyon / / Company Crucell Holland B.V. / Crucell Sweden AB / Valneva SE / Dukoral / / Country Switzerland / France / Sweden / United States / Canada / / Currency EUR / / Event Security Buyback / M&A / Product Issues / / IndustryTerm contaminated food / attractive pharmaceutical segment / manufacturing site / biotechnology / vaccine sales infrastructure / / MedicalCondition travelers’ diarrhea / traveler’s diarrhea / very serious disease / cholera / Japanese encephalitis / severe diarrhea / / Position fully-integrated vaccines player / / Product food / / Technology biotechnology / / SocialTag Microbiology Vaccines Pandemics Crucell Cholera vaccine Enterotoxigenic Escherichia coli Forward-looking statement Influenza Cholera Medicine

Valneva Signs an Agreement to Acquire Dukoral® Vaccine Agreement includes Crucell Sweden AB, the Dukoral franchise and Nordic vaccine sales infrastructure Lyon (France), January 5, 2015 – European biotechnology companAdd to Reading List